Pharmacophore modeling: advances, limitations, and current utility in drug discovery

被引:82
|
作者
Qing, Xiaoyu [1 ]
Lee, Xiao Yin [2 ]
De Raeymaeker, Joren [1 ]
Tame, Jeremy Rh [3 ]
Zhang, Kam Yj [2 ]
De Maeyer, Marc [1 ]
Voet, Arnout Rd [1 ,2 ]
机构
[1] Katholieke Univ Leuven, Dept Chem, Lab Biomol Modelling, Heverlee, Belgium
[2] RIKEN, Ctr Life Sci Technol, Struct Bioinformat Team, Yokohama, Kanagawa, Japan
[3] Yokohama City Univ, Drug Design Lab, Yokohama, Kanagawa, Japan
关键词
ADME-tox; computer-aided drug design; pharmacophore fingerprint; protein design; virtual screening;
D O I
10.2147/JRLCR.S46843
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Pharmacophore modeling is a successful yet very diverse subfield of computer-aided drug design. The concept of the pharmacophore has been widely applied to the rational design of novel drugs. In this paper, we review the computational implementation of this concept and its common usage in the drug discovery process. Pharmacophores can be used to represent and identify molecules on a 2D or 3D level by schematically depicting the key elements of molecular recognition. The most common application of pharmacophores is virtual screening, and different strategies are possible depending on the prior knowledge. However, the pharmacophore concept is also useful for ADME-tox modeling, side effect, and off-target prediction as well as target identification. Furthermore, pharmacophores are often combined with molecular docking simulations to improve virtual screening. We conclude this review by summarizing the new areas where significant progress may be expected through the application of pharmacophore modeling; these include protein-protein interaction inhibitors and protein design.
引用
收藏
页码:81 / 92
页数:12
相关论文
共 50 条
  • [1] Pharmacophore modeling and applications in drug discovery: challenges and recent advances
    Yang, Sheng-Yong
    [J]. DRUG DISCOVERY TODAY, 2010, 15 (11-12) : 444 - 450
  • [2] Recent advances in pharmacophore modeling and its application to anti-influenza drug discovery
    Shin, Woo-Jin
    Seong, Baik Lin
    [J]. EXPERT OPINION ON DRUG DISCOVERY, 2013, 8 (04) : 411 - 426
  • [3] Pharmacophore Modeling in drug discovery and development: An overview
    Khedkar, Santosh A.
    Malde, Alpeshkumar K.
    Coutinho, Evans C.
    Srivastava, Sudha
    [J]. MEDICINAL CHEMISTRY, 2007, 3 (02) : 187 - 197
  • [4] Pharmacophore Modeling in Drug Design: Recent Advances
    Guner, Osman F.
    [J]. CURRENT COMPUTER-AIDED DRUG DESIGN, 2011, 7 (03) : 158 - 158
  • [5] The Development of Pharmacophore Modeling: Generation and Recent Applications in Drug Discovery
    Lu, Xin
    Yang, Hongyu
    Chen, Yao
    Li, Qi
    He, Si-yu
    Jiang, Xueyang
    Feng, Feng
    Qu, Wei
    Sun, Haopeng
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2018, 24 (29) : 3424 - 3439
  • [6] ON THE UTILITY OF MOLECULAR MODELING FOR NEW DRUG DISCOVERY
    GUND, P
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1989, 197 : 18 - PHYS
  • [7] Current advances in drug discovery for Chagas disease
    Scarim, Caue Benito
    Jornada, Daniela Hartmann
    Chelucci, Rafael Consolin
    de Almeida, Leticia
    dos Santos, Jean Leandro
    Chin, Chung Man
    [J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 155 : 824 - 838
  • [8] Pharmacophore modelling: applications in drug discovery
    Langer, Thierry
    Hoffmann, Remy D.
    [J]. EXPERT OPINION ON DRUG DISCOVERY, 2006, 1 (03) : 261 - 267
  • [9] Fluorescence lifetime assays: current advances and applications in drug discovery
    Pritz, Stephan
    Doering, Klaus
    Woelcke, Julian
    Hassiepen, Ulrich
    [J]. EXPERT OPINION ON DRUG DISCOVERY, 2011, 6 (06) : 663 - 670
  • [10] Current Approaches to Drug Discovery for Chagas Disease: Methodological Advances
    Scarim, Caue B.
    Chin, Chung M.
    [J]. COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2019, 22 (08) : 509 - 520